However, our sensitivity analysis, excluding people with diabetes who were taking oral glucose-lowering drugs, with or without insulin, or had missing information regarding glucose-lowering therapies, showed that the outcomes were essentially unchanged. This evidence concerns the gene INS and diabetes mellitus.